FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092274945> ?p ?o ?g. }

• W3092274945 endingPage "5524" @default.
• W3092274945 startingPage "5511" @default.
• W3092274945 abstract "This study aimed to investigate the antitumor effect of arsenic trioxide (ATO)-loaded CalliSpheres® microspheres (CSM) by transarterial chemoembolization (TACE) in rabbits with VX2 liver tumors. A total of 120 VX2 liver tumor rabbits were randomized into four groups (N = 30 for each group), which received ATO-loaded CSM by TACE (CSM-ATO group), ATO by conventional TACE (cTACE-ATO group), transcatheter arterial embolization using CSM (TAE-CSM group), and saline arterial injection (control group). Five rabbits in each group were sacrificed at 12 h, 3 d, 7 d and 14 d, and then tumor proliferation, apoptosis, and angiogenesis/epithelial-mesenchymal transition (EMT) markers were detected. Tumor volume, metastasis status and ascites were assessed at 14 d. Ten rabbits in each group were observed until death for accumulating survival calculation. Tumor volume and ascites were decreased in the CSM-ATO group compared to the cTACE-ATO and TAE-CSM groups. Pulmonary, abdominal wall and omentum metastases were reduced while accumulating survival was increased in the CSM-ATO group compared to the TAE-CSM group. However, no difference in metastasis foci or survival between the CSM-ATO and cTACE-ATO groups was discovered. Meanwhile, tumor apoptosis was promoted while proliferation was suppressed in the CSM-ATO group compared to the cTACE-ATO and TAE-CSM groups. Additionally, HIF-1α, VEGF and microvessel density were decreased in the CSM-ATO group compared to the cTACE-ATO and TAE-CSM groups. Additionally, twist, N-cadherin, vimentin and MMP-9 were reduced while E-cadherin was enhanced in the CSM-ATO group compared to the cTACE-ATO and TAE-CSM groups. In conclusion, ATO-loaded CSM by TACE suppressed tumor growth, angiogenesis, and metastasis and elongated survival in VX2 liver tumor rabbits." @default.
• W3092274945 created "2020-10-15" @default.
• W3092274945 creator A5003842582 @default.
• W3092274945 creator A5013996193 @default.
• W3092274945 creator A5019560977 @default.
• W3092274945 creator A5032533121 @default.
• W3092274945 creator A5038668046 @default.
• W3092274945 creator A5049138170 @default.
• W3092274945 creator A5074864641 @default.
• W3092274945 creator A5076516501 @default.
• W3092274945 date "2020-01-01" @default.
• W3092274945 modified "2023-09-26" @default.
• W3092274945 title "Antitumor properties of arsenic trioxide-loaded CalliSpheres® microspheres by transarterial chemoembolization in VX2 liver tumor rabbits: suppression of tumor growth, angiogenesis, and metastasis and elongation of survival." @default.
• W3092274945 cites W1978057379 @default.
• W3092274945 cites W1979613985 @default.
• W3092274945 cites W2010265466 @default.
• W3092274945 cites W2020267062 @default.
• W3092274945 cites W2021471642 @default.
• W3092274945 cites W2031020207 @default.
• W3092274945 cites W2031203180 @default.
• W3092274945 cites W2036008499 @default.
• W3092274945 cites W2041419378 @default.
• W3092274945 cites W2043162780 @default.
• W3092274945 cites W2072403138 @default.
• W3092274945 cites W2092759077 @default.
• W3092274945 cites W2122906481 @default.
• W3092274945 cites W2123724074 @default.
• W3092274945 cites W2168041959 @default.
• W3092274945 cites W2232663846 @default.
• W3092274945 cites W2236150109 @default.
• W3092274945 cites W2295737782 @default.
• W3092274945 cites W2407812106 @default.
• W3092274945 cites W2461796595 @default.
• W3092274945 cites W2586218082 @default.
• W3092274945 cites W2801759559 @default.
• W3092274945 cites W2802145014 @default.
• W3092274945 cites W2806486243 @default.
• W3092274945 cites W2889646458 @default.
• W3092274945 cites W2922394035 @default.
• W3092274945 cites W2950240845 @default.
• W3092274945 cites W2952031812 @default.
• W3092274945 cites W2982642652 @default.
• W3092274945 cites W2990204247 @default.
• W3092274945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7540148" @default.
• W3092274945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33042434" @default.
• W3092274945 hasPublicationYear "2020" @default.
• W3092274945 type Work @default.
• W3092274945 sameAs 3092274945 @default.
• W3092274945 citedByCount "5" @default.
• W3092274945 countsByYear W30922749452021 @default.
• W3092274945 countsByYear W30922749452022 @default.
• W3092274945 countsByYear W30922749452023 @default.
• W3092274945 crossrefType "journal-article" @default.
• W3092274945 hasAuthorship W3092274945A5003842582 @default.
• W3092274945 hasAuthorship W3092274945A5013996193 @default.
• W3092274945 hasAuthorship W3092274945A5019560977 @default.
• W3092274945 hasAuthorship W3092274945A5032533121 @default.
• W3092274945 hasAuthorship W3092274945A5038668046 @default.
• W3092274945 hasAuthorship W3092274945A5049138170 @default.
• W3092274945 hasAuthorship W3092274945A5074864641 @default.
• W3092274945 hasAuthorship W3092274945A5076516501 @default.
• W3092274945 hasConcept C121608353 @default.
• W3092274945 hasConcept C126322002 @default.
• W3092274945 hasConcept C126894567 @default.
• W3092274945 hasConcept C185592680 @default.
• W3092274945 hasConcept C190283241 @default.
• W3092274945 hasConcept C2777397205 @default.
• W3092274945 hasConcept C2779013556 @default.
• W3092274945 hasConcept C2779124032 @default.
• W3092274945 hasConcept C2780386689 @default.
• W3092274945 hasConcept C2780394083 @default.
• W3092274945 hasConcept C2780496750 @default.
• W3092274945 hasConcept C502942594 @default.
• W3092274945 hasConcept C55493867 @default.
• W3092274945 hasConcept C71924100 @default.
• W3092274945 hasConcept C90924648 @default.
• W3092274945 hasConceptScore W3092274945C121608353 @default.
• W3092274945 hasConceptScore W3092274945C126322002 @default.
• W3092274945 hasConceptScore W3092274945C126894567 @default.
• W3092274945 hasConceptScore W3092274945C185592680 @default.
• W3092274945 hasConceptScore W3092274945C190283241 @default.
• W3092274945 hasConceptScore W3092274945C2777397205 @default.
• W3092274945 hasConceptScore W3092274945C2779013556 @default.
• W3092274945 hasConceptScore W3092274945C2779124032 @default.
• W3092274945 hasConceptScore W3092274945C2780386689 @default.
• W3092274945 hasConceptScore W3092274945C2780394083 @default.
• W3092274945 hasConceptScore W3092274945C2780496750 @default.
• W3092274945 hasConceptScore W3092274945C502942594 @default.
• W3092274945 hasConceptScore W3092274945C55493867 @default.
• W3092274945 hasConceptScore W3092274945C71924100 @default.
• W3092274945 hasConceptScore W3092274945C90924648 @default.
• W3092274945 hasIssue "9" @default.
• W3092274945 hasLocation W30922749451 @default.
• W3092274945 hasOpenAccess W3092274945 @default.
• W3092274945 hasPrimaryLocation W30922749451 @default.
• W3092274945 hasRelatedWork W1576290062 @default.
• W3092274945 hasRelatedWork W1578863196 @default.
• W3092274945 hasRelatedWork W2056816829 @default.

• next